Matches in Wikidata for { <http://www.wikidata.org/entity/Q90345062> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q90345062 description "article scientifique publié en 2018" @default.
- Q90345062 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q90345062 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90345062 description "scientific article published on 17 July 2018" @default.
- Q90345062 description "wetenschappelijk artikel" @default.
- Q90345062 description "наукова стаття, опублікована в липні 2018" @default.
- Q90345062 name "Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study" @default.
- Q90345062 name "Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study" @default.
- Q90345062 type Item @default.
- Q90345062 label "Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study" @default.
- Q90345062 label "Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study" @default.
- Q90345062 prefLabel "Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study" @default.
- Q90345062 prefLabel "Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study" @default.
- Q90345062 P1433 Q90345062-4D1ED074-1385-4B58-BC08-6B1A1A0850D7 @default.
- Q90345062 P1476 Q90345062-099D7D74-CB00-4261-BBC6-9F28B83BB59E @default.
- Q90345062 P2093 Q90345062-7DD8D69A-D9BC-450E-B50B-CD8167B3FCF5 @default.
- Q90345062 P304 Q90345062-2460E240-F6A4-445F-8F00-7B9E80C00AED @default.
- Q90345062 P31 Q90345062-6379D622-2167-4F2F-B690-36CA0F1B6218 @default.
- Q90345062 P356 Q90345062-1CD06D4D-CF4D-40A2-9140-08A9617B7253 @default.
- Q90345062 P433 Q90345062-59FB7755-8A74-40BA-8A57-6B60A4009304 @default.
- Q90345062 P478 Q90345062-063491BD-5D1F-48C6-ADF2-75753036606B @default.
- Q90345062 P577 Q90345062-87836883-BDDD-43CD-A1C3-B3E39DFB027F @default.
- Q90345062 P698 Q90345062-39832FED-A2E3-47C4-A027-9CB6B986B56B @default.
- Q90345062 P356 J.ACURO.2018.06.002 @default.
- Q90345062 P698 30025617 @default.
- Q90345062 P1433 Q15746072 @default.
- Q90345062 P1476 "Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study" @default.
- Q90345062 P2093 "A Alcántara Montero" @default.
- Q90345062 P304 "51-52" @default.
- Q90345062 P31 Q13442814 @default.
- Q90345062 P356 "10.1016/J.ACURO.2018.06.002" @default.
- Q90345062 P433 "1" @default.
- Q90345062 P478 "43" @default.
- Q90345062 P577 "2018-07-17T00:00:00Z" @default.
- Q90345062 P698 "30025617" @default.